Weitz & Luxenberg attorney Jared Scotto was recently named a 2023 New York Law Journal Distinguished Leader. The award honors lawyers with great performances, while…
Read MorePast Results: Drugs & Devices
Category: Consumer, Drugs & Devices
$500 Million Cost Savings for Eli Lilly Insulin Settlement
Weitz & Luxenberg is announcing a major victory in our class action lawsuit on behalf of people living with diabetes. Legal counsel for plaintiffs…
Category: Drugs & Devices
A $230 Million Opioid Settlement with Walgreens Reached for San Francisco Represented by W&L and Co-Counsel
On May 17, 2023, San Francisco City Attorney David Chiu announced Walgreens agreed to pay the People of San Francisco $230 million for its…
Category: Consumer, Drugs & Devices
W&L and Co-Counsel Reach $235M Settlement in Altria E-Cig Youth Vaping Crisis
Weitz & Luxenberg and co-lead counsel are pleased to announce a historic $235 million settlement with defendant Altria Group, Inc., in the federal multidistrict…
Category: Consumer, Drugs & Devices
Plaintiffs’ Co-Lead Counsel Announce Four Major Settlements with JUUL Labs, Inc. Addressing U.S. Youth E-Cigarette Usage
The four settlements with JUUL Labs announced on December 6 resolve the personal injury, consumer class action, government entity, and tribal harm cases brought…
Category: Drugs & Devices
Resolution Reached in Stryker Hips Lawsuit
On November 3, 2014, a global settlement program involving Stryker’s Rejuvenate and ABGII modular hip implants was executed before and announced by Superior Court Judge Brian R. Martinotti in Bergen County, New Jersey. The settlement was finalized after four months of negotiations before retired United States Magistrate Judge Diane Welsh of JAMS in Philadelphia. Stryker…